IL21 and systemic sclerosis: SSc patients had higher serum levels of both IL-4 and IL-21 compared to HCs, and the serum levels of these cytokines were correlated with a reduction in the diffusion lung capacity for carbon monoxide (DLco) and the radiological extension of interstitial lung disease (ILD) in SSc patients [18].